Risk of COVID-19 Disease, Dialysis Unit Attributes, and Infection Control Strategy among London In-Center Hemodialysis Patients.


Journal

Clinical journal of the American Society of Nephrology : CJASN
ISSN: 1555-905X
Titre abrégé: Clin J Am Soc Nephrol
Pays: United States
ID NLM: 101271570

Informations de publication

Date de publication:
08 2021
Historique:
received: 02 03 2021
accepted: 27 04 2021
pubmed: 3 6 2021
medline: 17 8 2021
entrez: 2 6 2021
Statut: ppublish

Résumé

Patients receiving in-center hemodialysis treatment face unique challenges during the coronavirus disease 2019 (COVID-19) pandemic, specifically the need to attend for treatment that prevents self-isolation. Dialysis unit attributes and isolation strategies that might reduce dialysis center COVID-19 infection rates have not been previously examined. We explored the role of variables, including community disease burden, dialysis unit attributes (size and layout), and infection control strategies, on rates of COVID-19 among patients receiving in-center hemodialysis in London, United Kingdom, between March 2, 2020 and May 31, 2020. The two outcomes were defined as ( Data on 5755 patients dialyzing in 51 units were analyzed; 990 (17%) tested positive and 465 (8%) were admitted with suspected COVID-19 between March 2 and May 31, 2020. Outcomes were associated with age, diabetes, local community COVID-19 rates, and dialysis unit size. A greater number of available side rooms and the introduction of mask policies for asymptomatic patients were inversely associated with outcomes. No association was seen with sex, ethnicity, or deprivation indices, nor with any of the different isolation strategies. Rates of COVID-19 in the in-center hemodialysis population relate to individual factors, underlying community transmission, unit size, and layout.

Sections du résumé

BACKGROUND AND OBJECTIVES
Patients receiving in-center hemodialysis treatment face unique challenges during the coronavirus disease 2019 (COVID-19) pandemic, specifically the need to attend for treatment that prevents self-isolation. Dialysis unit attributes and isolation strategies that might reduce dialysis center COVID-19 infection rates have not been previously examined.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS
We explored the role of variables, including community disease burden, dialysis unit attributes (size and layout), and infection control strategies, on rates of COVID-19 among patients receiving in-center hemodialysis in London, United Kingdom, between March 2, 2020 and May 31, 2020. The two outcomes were defined as (
RESULTS
Data on 5755 patients dialyzing in 51 units were analyzed; 990 (17%) tested positive and 465 (8%) were admitted with suspected COVID-19 between March 2 and May 31, 2020. Outcomes were associated with age, diabetes, local community COVID-19 rates, and dialysis unit size. A greater number of available side rooms and the introduction of mask policies for asymptomatic patients were inversely associated with outcomes. No association was seen with sex, ethnicity, or deprivation indices, nor with any of the different isolation strategies.
CONCLUSIONS
Rates of COVID-19 in the in-center hemodialysis population relate to individual factors, underlying community transmission, unit size, and layout.

Identifiants

pubmed: 34074636
pii: 01277230-202108000-00015
doi: 10.2215/CJN.03180321
pmc: PMC8455047
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1237-1246

Investigateurs

Asgari Elham (A)
Ashby Damien (A)
Banerjee Debasish (B)
Blakey Sarah (B)
Bramham Kate (B)
Brewster Rosalind (B)
Briade-Azikwe Dandisonba (BA)
Cairns Hugh (C)
Caplin Ben (C)
Chowdhury Paramit (C)
Clark Grace (C)
Cole Nicholas (C)
Corbett Richard (C)
Cove-Smith Andrea (CS)
Cronin Helen (C)
Davari Maria (D)
Dias Abigail (D)
Evans Kevin (E)
Forbes Suzanne (F)
Ford Martin (F)
Frankel Andrew (F)
Gnansampanthan Sahana (G)
Goodlad Catriona (G)
Hayes Nathan (H)
Hendra Heidy (H)
Hull Richard (H)
Kumar Nicola (K)
Lioudaki Eirini (L)
Loucaidou Marina (L)
Makanjuola David (M)
Manson Bethia (M)
McCafferty Kieran (M)
McGuinness Daniel (M)
Neradova Aegida (N)
Phanish Mysore (P)
Price Katherine (P)
Rajakariar Ravi (R)
Rankin Alex (R)
Roper Tayeba (R)
Roth Noam (R)
Salama Alan (S)
Sarnowski Alexander (S)
Schott Cassim (S)
Sharpe Claire (S)
Srinivasa Vinay (S)
Tandaric Damir (T)
Thyagarajan Sujanita (T)
Vajgel Gisele (V)
Young Gregor (Y)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 by the American Society of Nephrology.

Références

Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J, Gharavi AG, Mohan S, Husain SA: Presentation and outcomes of patients with ESKD and COVID-19. J Am Soc Nephrol 31: 1409–1415, 2020
UK Renal Registry: COVID-19 surveillance report for renal centres in the UK: All regions and centres. Bristol, United Kingdom, UK Renal Registry, 2020
Department of Health: Coronavirus (COVID-19) in the UK, 2020. Available at: https://coronavirus.data.gov.uk . Accessed June 16, 2020
Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, Kirmizis D, Schneditz D, van der Sande F, Mitra S: Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant 35: 737–741, 2020
Department of Health: Guidance on infection prevention and control for COVID-19, 2020. Available at: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-prevention-and-control#history . Accessed July 1, 2020
Corbett RW, Blakey S, Nitsch D, Loucaidou M, McLean A, Duncan N, Ashby DR; West London Renal and Transplant Centre: Epidemiology of COVID-19 in an urban dialysis center. J Am Soc Nephrol 31: 1815–1823, 2020
Office for National Statistics: Index of Multiple Deprivation (December 2019) Lookup in England, 2019. Available at: https://geoportal.statistics.gov.uk/datasets/index-of-multiple-deprivation-december-2019-lookup-in-england . Accessed June 16, 2020
Austin PC: A tutorial on multilevel survival analysis: Methods, models and applications. Int Stat Rev 85: 185–203, 2017
Couchoud C, Bayer F, Ayav C, Béchade C, Brunet P, Chantrel F, Frimat L, Galland R, Hourmant M, Laurain E, Lobbedez T, Mercadal L, Moranne O; French REIN registry: Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients. Kidney Int 98: 1519–1529, 2020
Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, Maffei C, Possenti S, Lucca B, Cortinovis R, Terlizzi V, Zappa M, Saccà C, Pezzini E, Calcaterra E, Piarulli P, Guerini A, Boni F, Gallico A, Mucchetti A, Affatato S, Bove S, Bracchi M, Costantino EM, Zubani R, Camerini C, Gaggia P, Movilli E, Bossini N, Gaggiotti M, Scolari F: A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int 98: 20–26, 2020
Keller N, Chantrel F, Krummel T, Bazin-Kara D, Faller AL, Muller C, Nussbaumer T, Ismer M, Benmoussa A, Brahim-Bouna M, Beier S, Perrin P, Hannedouche T: Impact of first-wave COronaVIrus disease 2019 infection in patients on haemoDIALysis in Alsace: The observational COVIDIAL study. Nephrol Dial Transplant 35: 1338–1411, 2020
Xiong F, Tang H, Liu L, Tu C, Tian JB, Lei CT, Liu J, Dong JW, Chen WL, Wang XH, Luo D, Shi M, Miao XP, Zhang C: Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol 31: 1387–1397, 2020
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, MacKenna B, Tomlinson L, Douglas IJ, Rentsch CT, Mathur R, Wong AYS, Grieve R, Harrison D, Forbes H, Schultze A, Croker R, Parry J, Hester F, Harper S, Perera R, Evans SJW, Smeeth L, Goldacre B: Factors associated with COVID-19-related death using OpenSAFELY. Nature 584: 430–436, 2020
Ioannou GN, Locke E, Green P, Berry K, O’Hare AM, Shah JA, Crothers K, Eastment MC, Dominitz JA, Fan VS: Risk factors for hospitalization, mechanical ventilation, or death among 10,131 US veterans with SARS-CoV-2 infection. JAMA Netw Open 3: e2022310, 2020.
Jones NR, Qureshi ZU, Temple RJ, Larwood JPJ, Greenhalgh T, Bourouiba L: Two metres or one: What is the evidence for physical distancing in COVID-19? BMJ 370: m3223, 2020
Clarke C, Prendecki M, Dhutia A, Ali MA, Sajjad H, Shivakumar O, Lightstone L, Kelleher P, Pickering MC, Thomas D, Charif R, Griffith M, McAdoo SP, Willicombe M: High prevalence of asymptomatic COVID-19 infection in hemodialysis patients detected using serologic screening. J Am Soc Nephrol 31: 1969–1975, 2020

Auteurs

Ben Caplin (B)

Department of Renal Medicine, University College London, London, United Kingdom.
Renal Services, Royal Free London NHS Foundation Trust, London, United Kingdom.

Damien Ashby (D)

Kidney and Transplant Services, Imperial College Healthcare NHS Trust, London, United Kingdom.

Kieran McCafferty (K)

Renal Service, Barts Health NHS Trust, London, United Kingdom.

Richard Hull (R)

Renal Department, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom.

Elham Asgari (E)

Kidney Services, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.

Martin L Ford (ML)

Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Faculty of Life Sciences & Medicine, Kings College London, London, United Kingdom.

Nicholas Cole (N)

South West Thames Renal and Transplantation Unit, Epsom and St. Helier University Hospitals NHS Trust, London, United Kingdom.

Marilina Antonelou (M)

Department of Renal Medicine, University College London, London, United Kingdom.
Renal Services, Royal Free London NHS Foundation Trust, London, United Kingdom.

Sarah A Blakey (SA)

Kidney and Transplant Services, Imperial College Healthcare NHS Trust, London, United Kingdom.

Vinay Srinivasa (V)

Renal Service, Barts Health NHS Trust, London, United Kingdom.

Dandisonba C B Braide-Azikwe (DCB)

Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Tayeba Roper (T)

Kidney Services, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.

Grace Clark (G)

Renal Services, Royal Free London NHS Foundation Trust, London, United Kingdom.

Helen Cronin (H)

Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Nathan J Hayes (NJ)

Renal Services, North Middlesex University Hospital NHS Trust, London, United Kingdom.

Bethia Manson (B)

Renal Services, Royal Free London NHS Foundation Trust, London, United Kingdom.

Alexander Sarnowski (A)

Renal Department, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom.

Richard Corbett (R)

Kidney and Transplant Services, Imperial College Healthcare NHS Trust, London, United Kingdom.

Kate Bramham (K)

Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Faculty of Life Sciences & Medicine, Kings College London, London, United Kingdom.

Eirini Lioudaki (E)

Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Faculty of Life Sciences & Medicine, Kings College London, London, United Kingdom.

Nicola Kumar (N)

Kidney Services, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.

Andrew Frankel (A)

Kidney and Transplant Services, Imperial College Healthcare NHS Trust, London, United Kingdom.

David Makanjuola (D)

South West Thames Renal and Transplantation Unit, Epsom and St. Helier University Hospitals NHS Trust, London, United Kingdom.

Claire C Sharpe (CC)

Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Faculty of Life Sciences & Medicine, Kings College London, London, United Kingdom.

Debasish Banerjee (D)

Renal Department, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom.

Alan D Salama (AD)

Department of Renal Medicine, University College London, London, United Kingdom.
Renal Services, Royal Free London NHS Foundation Trust, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH